{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:08:42Z","timestamp":1773299322220,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["EPI08014.036.02"],"award-info":[{"award-number":["EPI08014.036.02"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.4065\/84.10.864","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T22:39:42Z","timestamp":1254436782000},"page":"864-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Correlates for Completion of 3-Dose Regimen of HPV Vaccine in Female Members of a Managed Care Organization"],"prefix":"10.4065","volume":"84","author":[{"given":"Chun","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Velicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff M.","family":"Slezak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.4065\/84.10.864_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.4065\/84.10.864_bib2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"issue":"RR-2","key":"10.4065\/84.10.864_bib3","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"40","key":"10.4065\/84.10.864_bib4","first-page":"1100","article-title":"Vaccination coverage among adolescents aged 13-17 years - United States, 2007","volume":"57","author":"Department of Health and Human Services","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.4065\/84.10.864_bib5","first-page":"143","article-title":"Understanding and enhancing compliance with the second dose of hepatitis B vaccine: a cohort analysis and a randomized controlled trial","volume":"157","author":"Sellors","year":"1997","journal-title":"CMAJ"},{"issue":"5","key":"10.4065\/84.10.864_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.annepidem.2003.07.002","article-title":"Limitations and potential uses of census-based data on ethnicity in a diverse community","volume":"14","author":"Chen","year":"2004","journal-title":"Ann Epidemiol"},{"issue":"8","key":"10.4065\/84.10.864_bib7","first-page":"1759","article-title":"Screening for cervical cancer: recommendations and rationale","volume":"67","author":"U.S. Preventive Services Task Force","year":"2003","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.4065\/84.10.864_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1353\/hpu.2010.0482","article-title":"Relationships between socioeconomic status and race-specific cervical cancer incidence in the United States, 1973-1992","volume":"9","author":"Liu","year":"1998","journal-title":"J Health Care Poor Underserved"},{"issue":"10","key":"10.4065\/84.10.864_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10552-007-9056-y","article-title":"Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003","volume":"18","author":"McDougall","year":"2007","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.4065\/84.10.864_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpag.2005.09.004","article-title":"Attitudes about human papillomavirus vaccine among family physicians","volume":"18","author":"Riedesel","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"10.4065\/84.10.864_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1525-1497.1998.00115.x","article-title":"Chronic disease as a barrier to breast and cervical cancer screening","volume":"13","author":"Kiefe","year":"1998","journal-title":"J Gen Intern Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961160503X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961160503X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:14:46Z","timestamp":1706001286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961160503X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S002561961160503X"],"URL":"https:\/\/doi.org\/10.4065\/84.10.864","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlates for Completion of 3-Dose Regimen of HPV Vaccine in Female Members of a Managed Care Organization","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/84.10.864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}